UPClytics
EnglishDeutsch
Sign inSign up
View All Parties

Regeneron Pharmaceuticals Inc.

Operating company
Total cases
10 (3 active)
Claimant-side
4
Respondent-side
6

Regeneron Pharmaceuticals Inc. has been party to ten Unified Patent Court cases, 4 times as claimant and 6 times as respondent. The most recent on record is UPC CFI 2221/2025 at the Munich Central Division, brought by Amgen Inc.

Adversary analytics require an account

Sign in to see top opponents and the firms representing each side.

Sign in or create an account
Recent cases
View all cases
  • 2025-12-23UPC CFI 2221/2025—Amgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2025-07-11UPC CoA 646/2025—Amgen NV v Regeneron Pharmaceuticals Inc.
  • 2025-02-28UPC CFI 195/2025WithdrawnSanofi Biotechnology SAS v Amgen Inc.
  • 2024-09-13UPC CoA 529/2024Patent maintainedAmgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2024-05-03CC 24999/2024—Amgen S.R.L. v Regeneron Pharmaceuticals Inc.
  • 2023-11-10CC 586764/2023RevokedRegeneron Pharmaceuticals Inc. v Amgen Inc.
  • 2023-09-13UPC CoA 320/2023Procedural onlySanofi-Aventis Deutschland GmbH v Amgen Inc.
  • 2023-06-26UPC CFI 14/2023Procedural onlyAmgen Inc. v Sanofi-Aventis Deutschland GmbH
  • —ACT 597355/2023Not infringedSanofi Biotechnologies SAS v Amgen Inc.
  • —ORD 43914/2024Procedural onlyAmgen Inc. v Sanofi-Aventis Deutschland GmbH